Novartis CEO: Our Innovation Will Be Rewarded

In this video

Share

Novartis CEO: Our Innovation Will Be Rewarded

Joe Jimenez, CEO of Novartis, tells CNBC that 2012 was a transition year for Novartis with 17 major drug approvals.
08:34
Wed, Jan 23 20132:10 AM EST